JP2022527542A5 - - Google Patents
Info
- Publication number
- JP2022527542A5 JP2022527542A5 JP2021558985A JP2021558985A JP2022527542A5 JP 2022527542 A5 JP2022527542 A5 JP 2022527542A5 JP 2021558985 A JP2021558985 A JP 2021558985A JP 2021558985 A JP2021558985 A JP 2021558985A JP 2022527542 A5 JP2022527542 A5 JP 2022527542A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- composition according
- ifn
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024152418A JP2025000638A (ja) | 2019-04-04 | 2024-09-04 | 抗ＩＦＮ－α／ω抗体の投与方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962829317P | 2019-04-04 | 2019-04-04 | |
| US62/829,317 | 2019-04-04 | ||
| PCT/IB2020/053221 WO2020202106A1 (en) | 2019-04-04 | 2020-04-03 | Method of administration of an anti-ifn-alpha/-omega antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152418A Division JP2025000638A (ja) | 2019-04-04 | 2024-09-04 | 抗ＩＦＮ－α／ω抗体の投与方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527542A JP2022527542A (ja) | 2022-06-02 |
| JP2022527542A5 true JP2022527542A5 (https=) | 2023-03-27 |
Family
ID=72662887
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021558985A Pending JP2022527542A (ja) | 2019-04-04 | 2020-04-03 | 抗ＩＦＮ－α／ω抗体の投与方法 |
| JP2024152418A Pending JP2025000638A (ja) | 2019-04-04 | 2024-09-04 | 抗ＩＦＮ－α／ω抗体の投与方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152418A Pending JP2025000638A (ja) | 2019-04-04 | 2024-09-04 | 抗ＩＦＮ－α／ω抗体の投与方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12202892B2 (https=) |
| EP (1) | EP3947448A4 (https=) |
| JP (2) | JP2022527542A (https=) |
| MA (1) | MA55559A (https=) |
| WO (1) | WO2020202106A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022512796A (ja) | 2018-10-26 | 2022-02-07 | ヤンセン バイオテツク，インコーポレーテツド | Ｉ型インターフェロンシグネチャー及び使用方法 |
| CN120241997A (zh) | 2019-02-18 | 2025-07-04 | 伊莱利利公司 | 治疗性抗体制剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0490233A1 (de) * | 1986-03-10 | 1992-06-17 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung |
| US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| KR101225299B1 (ko) | 2003-12-10 | 2013-01-24 | 메다렉스, 인코포레이티드 | 인터페론 알파 항체 및 그의 용도 |
| CN101155831B (zh) | 2005-02-10 | 2015-08-19 | 贝勒研究院 | 抗干扰素α单克隆抗体及其使用方法 |
| CN102083859B (zh) | 2008-05-07 | 2014-09-17 | 阿哥斯医疗公司 | 人源化抗人干扰素-α抗体 |
| BR112013030242A2 (pt) * | 2011-05-25 | 2016-12-06 | Medimmune Llc | método de tratamento de um distúrbio autoimune em um sujeito humano |
| TWI713453B (zh) * | 2014-06-23 | 2020-12-21 | 美商健生生物科技公司 | 干擾素α及ω抗體拮抗劑 |
| TW201922780A (zh) * | 2017-09-25 | 2019-06-16 | 美商健生生物科技公司 | 以抗ｉｌ１２／ｉｌ２３抗體治療狼瘡之安全且有效之方法 |
-
2020
- 2020-04-03 JP JP2021558985A patent/JP2022527542A/ja active Pending
- 2020-04-03 MA MA055559A patent/MA55559A/fr unknown
- 2020-04-03 US US16/839,249 patent/US12202892B2/en active Active
- 2020-04-03 EP EP20783329.4A patent/EP3947448A4/en active Pending
- 2020-04-03 WO PCT/IB2020/053221 patent/WO2020202106A1/en not_active Ceased
-
2024
- 2024-09-04 JP JP2024152418A patent/JP2025000638A/ja active Pending
- 2024-12-09 US US18/974,431 patent/US20250376516A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1214043C (zh) | 抗γ－干扰素的人化抗体 | |
| JP2025172841A5 (https=) | ||
| US8178092B2 (en) | Methods of treating psoriasis by administration of antibodies to the p40 subunit of IL-12 and/or IL-23 | |
| JP2023548858A5 (https=) | ||
| EP3360896B1 (en) | Antibody to hepatitis b surface antigen and use thereof | |
| JP2018515493A5 (https=) | ||
| BRPI0806605A2 (pt) | métodos para tratar psorìase | |
| US20210324052A1 (en) | Formulations of anti-rsv antibodies and methods of use thereof | |
| JP2022527542A5 (https=) | ||
| WO2025223497A1 (zh) | 一种稳定的抗人IL-4Rα单克隆抗体制剂 | |
| US20230049011A1 (en) | Methods of treating warm autoimmune hemolytic anemia using anti-fcrn antibodies | |
| JP2024511853A5 (https=) | ||
| JP2022534494A5 (https=) | ||
| TW202302147A (zh) | 使用抗baffr抗體治療狼瘡腎炎 | |
| WO2021018191A1 (zh) | Il-17拮抗剂治疗自身免疫疾病的方法 | |
| CN116685351A (zh) | Empacta的结果：一项用于评估托珠单抗在患有covid-19肺炎的住院患者中的功效和安全性的随机、双盲、安慰剂对照、多中心研究 | |
| US20250230238A1 (en) | Methods and compositions for treating systemic lupus erythematous (sle) | |
| JP2022502380A5 (https=) | ||
| CA3115708C (en) | Formulations of anti-rsv antibodies and methods of use thereof | |
| EP4334351A1 (en) | Treatment for systemic lupus erythematosus using anti-baffr antibodies | |
| WO2025188845A1 (en) | STABLE FORMULATIONS FOR TNFα ANTIBODIES AND USES THEREOF | |
| JP2025526370A (ja) | 免疫グロブリン様転写物７（ｉｌｔ７）結合タンパク質を含む製剤 | |
| KR20250173550A (ko) | 자가면역 용혈성 빈혈(aiha) 치료를 위한 방법 및 조성물 | |
| CN120000779A (zh) | 抗il-5抗体治疗与嗜酸性粒细胞升高相关疾病的用途 | |
| TW202241505A (zh) | 抗il-17抗體治療自體免疫性疾病和炎症的方法 |